180 Wealth Advisors LLC Acquires 7,705 Shares of Grail, Inc. (NASDAQ:GRAL)

180 Wealth Advisors LLC boosted its stake in Grail, Inc. (NASDAQ:GRAL - Free Report) by 8.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 101,883 shares of the company's stock after buying an additional 7,705 shares during the period. 180 Wealth Advisors LLC owned 0.30% of Grail worth $2,602,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Crcm LP purchased a new position in shares of Grail during the fourth quarter valued at approximately $65,061,000. Sessa Capital IM L.P. purchased a new position in shares of Grail during the fourth quarter valued at approximately $53,550,000. Primecap Management Co. CA purchased a new position in shares of Grail during the fourth quarter valued at approximately $37,118,000. Baker BROS. Advisors LP purchased a new position in Grail in the 4th quarter worth approximately $29,098,000. Finally, Vanguard Group Inc. purchased a new position in Grail in the 4th quarter worth approximately $25,902,000.

Insiders Place Their Bets

In other news, President Joshua J. Ofman sold 48,213 shares of the business's stock in a transaction on Friday, May 2nd. The shares were sold at an average price of $33.93, for a total transaction of $1,635,867.09. Following the completion of the sale, the president now owns 511,460 shares of the company's stock, valued at $17,353,837.80. The trade was a 8.61% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Aaron Freidin sold 41,150 shares of the business's stock in a transaction on Friday, May 2nd. The shares were sold at an average price of $33.93, for a total transaction of $1,396,219.50. Following the sale, the chief financial officer now directly owns 294,020 shares of the company's stock, valued at approximately $9,976,098.60. The trade was a 12.28% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 194,948 shares of company stock valued at $6,583,130. Company insiders own 1.85% of the company's stock.

Grail Trading Up 1.5%

NASDAQ:GRAL traded up $0.59 during trading hours on Thursday, reaching $40.60. The company had a trading volume of 1,170,069 shares, compared to its average volume of 1,258,000. Grail, Inc. has a 52 week low of $12.33 and a 52 week high of $63.99. The firm has a market cap of $1.46 billion and a price-to-earnings ratio of -0.67. The firm's 50 day moving average price is $32.70 and its 200-day moving average price is $28.80.

Grail (NASDAQ:GRAL - Get Free Report) last posted its earnings results on Tuesday, May 13th. The company reported ($3.10) EPS for the quarter, topping analysts' consensus estimates of ($4.03) by $0.93. The company had revenue of $31.84 million during the quarter, compared to the consensus estimate of $35.80 million. On average, analysts forecast that Grail, Inc. will post -15.15 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on GRAL. Canaccord Genuity Group boosted their price objective on shares of Grail from $32.00 to $43.00 and gave the stock a "buy" rating in a report on Wednesday, May 14th. Morgan Stanley boosted their price objective on shares of Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a report on Tuesday, March 18th.

Grail Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.